Yes, most clinical trials pay participants for their time. How much depends on what the study involves, how long it lasts, and how much it asks of you physically. The median compensation for early-phase trials is about $3,070, with a typical daily rate around $196. Some short studies pay as little as $150, while longer inpatient stays can reach $13,000 or more.
How Much Clinical Trials Actually Pay
Payment varies enormously based on what a study requires. A simple vaccine study with no overnight stay might pay $150 total. A cancer drug study requiring 34 consecutive days and nights in a research clinic paid $13,000. Most fall somewhere in between, with $3,070 being the median total for Phase 1 trials, the earliest stage of drug testing.
The daily rate gives a better sense of what your time is worth. Across studies, the median works out to roughly $196 per day enrolled. That figure accounts for both the days you’re physically at the clinic and any follow-up period where you’re being monitored. Studies that require overnight confinement, blood draws, or other uncomfortable procedures generally pay more than those that just need you to show up for a quick check-in.
Why Early-Phase Trials Pay More
Phase 1 trials test a drug’s safety in healthy volunteers. You’re taking an experimental substance with no expectation that it will treat anything you have. Because you’re accepting risk without any personal medical benefit, these studies typically offer the highest compensation. The payment is meant to fairly recognize your time, effort, and discomfort.
Later-phase trials (Phase 2 and Phase 3) recruit people who actually have the condition the drug targets. These participants may benefit directly from the treatment, so payments tend to be lower or sometimes limited to covering expenses like travel and parking. Some late-phase trials don’t offer cash compensation at all, instead providing the experimental treatment and all related medical care at no cost.
How Payment Is Structured
You won’t usually receive one lump sum at the end. FDA guidance requires that payment not be entirely contingent on completing the full study. The logic is straightforward: if all your money is locked behind finishing, you might feel pressured to stay even if you want to drop out. That would undermine your ability to make a truly voluntary choice about participation.
Instead, most studies pay incrementally. You might receive a set amount per visit or per day of confinement, with payments issued on a regular schedule. A small completion bonus is common and considered acceptable, as long as it’s not so large that it feels coercive. If you withdraw halfway through, you’ll typically receive payment proportional to the time you’ve already contributed.
On top of the study compensation itself, many trials reimburse travel, parking, meals, and lodging separately. These reimbursements cover your actual out-of-pocket costs and are handled differently from the stipend you earn for participation.
What Determines How Much a Study Pays
Three main factors drive compensation levels. The first is time commitment. A study that needs you at the clinic for a single afternoon pays far less than one requiring weeks of overnight stays. The second is discomfort and inconvenience. Frequent blood draws, dietary restrictions, or staying confined to a research unit all push compensation higher. The third is how easy or hard it is to recruit participants. Studies targeting a rare condition or requiring a very specific health profile may pay more simply because fewer people qualify.
This supply-and-demand element means compensation can vary by location too. A research clinic in a city with many potential volunteers may offer different rates than one in an area where recruitment is difficult. Ethics review boards examine every study’s payment structure before it launches to make sure the amount is fair without being so high that it clouds participants’ judgment about the risks involved.
Taxes on Clinical Trial Income
Clinical trial payments count as taxable income. Starting in January 2026, the NIH will be required to report payments of $2,000 or more per calendar year to the IRS. If you hit that threshold, you’ll receive a 1099 form for miscellaneous income, and the IRS gets a copy as well.
Reimbursements for out-of-pocket expenses like parking, meals, and mileage are not taxable and don’t count toward the $2,000 reporting threshold. Only the compensation you receive for your actual participation is included. Even below the reporting threshold, you’re technically supposed to report the income, though enforcement has historically been minimal for small amounts.
Where to Find Paid Trials
ClinicalTrials.gov, maintained by the National Library of Medicine, is the most comprehensive database of active studies in the United States. It’s a government-run site that lists trials from academic medical centers, pharmaceutical companies, and government agencies. You can search by condition, location, and eligibility criteria, though not all listings prominently display compensation details. You may need to contact the study coordinator listed on the posting to ask about payment.
Beyond that, many research clinics and pharmaceutical companies recruit directly through their own websites. University medical centers often maintain volunteer registries you can sign up for. If you’re a healthy adult in a major metro area, you’ll likely find the most options, since Phase 1 research clinics tend to cluster near population centers.
What to Know Before You Sign Up
Every study must go through an ethics review before it can recruit a single participant. The review board examines whether the risks are reasonable relative to what’s being studied, whether the consent process is clear, and whether the payment is fair without being manipulative. You’ll receive a detailed consent document before enrolling that spells out exactly what will happen, what the known risks are, and how much you’ll be paid.
You can leave any clinical trial at any time for any reason. That right is non-negotiable, regardless of what the consent form says about completion bonuses or payment schedules. If a study requires confinement at a research facility, you’re free to walk out. You’ll forfeit future payments, but you should receive compensation for the portion you completed.
For healthy volunteers considering Phase 1 studies, the key tradeoff is real: you’re testing something that has never been given to humans before, or has limited human safety data. Serious adverse events in Phase 1 trials are uncommon, but they do happen. The compensation reflects that you’re accepting uncertainty in exchange for your time and willingness to contribute to medical research.